Press Release

PathoQuest achieves Illumina® Propel Certification

PathoQuest is pleased to announce that it has received Propel Certification from Illumina after successfully completing the requirements for achieving this recognition. This included demonstrating the ability to produce high-quality data on the NexSeq System following a streamlined and rigorous process. PathoQuest’s Propel Certification is valid for the company’s Biologics Genomic Service projects which utilize Illumina’s NGS library preparation and sequencing protocols.


Propel Certification enables our customers to feel confident that they are receiving the highest quality data, insight, and service when PathoQuest utilizes Illumina’s technology for projects.

EnglishFrenchGermanSpanish